Corporate governance is key to any company’s long-term success as it enables an organization to control risks, achieve their goals, and assure regulatory compliance throughout. Companies in the cannabis space are no different, and in fact, must implement more robust corporate governance policies and infrastructure than companies in most other industries as they’re uniquely operating within a highly-regulated industry subject to federal prohibition. Attorneys advising these companies must, therefore, be equipped to guide their cannabis clients as they navigate unchartered territory, adhering to corporate governance requirements and guidelines under state and federal law as well as implementing tried-and-true corporate governance practices implemented across every industry. This panel will discuss, among other things: (i) the goals of implementing solid corporate governance infrastructure including transparency, equity among shareholders, and maintaining the integrity and legitimacy of a cannabis company in particular; (ii) the importance of advising clients about best practices for effectively maintaining and enforcing corporate governance systems by, including, but not limited to, adhering to the often-overlooked federal guidelines from the United States Sentencing Commission; and (iii) the importance of implementing corporate governance controls and policies during a company’s infancy; and (iv) lessons learned from high-profile cannabis companies whose poor corporate governance practices had a damaging impact, including companies like Namaste Technologies.
This program is eligible for 1 hours of General CLE credit in 60-minute states, and 1.2 hours of General CLE credit in 50-minute states. Credit hours are estimated and are subject to each state’s approval and credit rounding rules.
INCBA webinars are eligible for credit in the following states: AR, AL, AK, AZ, CA, CO, CT,DE, GA, HI, IL, IN, MN, MS, MO, NV, NH, NJ, NM, NY, NC, ND, OH, OR, PA, TN, TX, UT, VT, WV, and WI . Additional states may be available for credit upon self-application by attendees. States typically decide whether a program qualifies for MCLE credit in their jurisdiction 4-8 weeks after the program application is submitted. For many live events, credit approval is not received prior to the program.
INCBA on demand programs are eligible for credit in the following states: AR, AL, AK, AZ, CA, CO, CT,DE, GA, HI, IL, IN, MN, MS, MO, NV, NH, NJ, NM, NY, NC, ND, OH, OR, PA, TN, TX, UT, VT, WV, and WI . Additional states may be available for credit upon self-application by attendees. States typically decide whether a program qualifies for MCLE credit in their jurisdiction 4-8 weeks after the program application is submitted.
For current accreditation status, please select your jurisdiction below.
|California Leg. 3013 (0.11 MB)||Available after Purchase|
|Chapter 8 of the Federal Sentencing Guidelines Manual (0.59 MB)||Available after Purchase|
|DOJ evaluation of Corporate Compliance Programs (0.26 MB)||Available after Purchase|
|Illinois Leg. 5812 (0.11 MB)||Available after Purchase|
|NY LEGIS 747 (0.12 MB)||Available after Purchase|
|NYSE Listed Companies - Independent Directors (0.11 MB)||Available after Purchase|
|NYSE Listed Companies - Independence Tests (0.12 MB)||Available after Purchase|
|NYSE Listed Companies - Corporate Governance Guidelines (0.12 MB)||Available after Purchase|
|NYSE Listed Companies - Code of Business Conduct and Ethics (0.12 MB)||Available after Purchase|
|NYSE Listed Companies - Related Party Transactions (0.10 MB)||Available after Purchase|
Amy McDougal, Founder and President at CLEAResources, LLC, helps companies effectively manage their greatest legal and regulatory risks. She designs compliance and ethics programs to mitigate legal risks so company executives can focus on business.
"Increased emphasis on business transparency makes ethical performance a corporate priority," says Amy. A company's legal counsel may lack experience in developing compliance and ethics programs. Amy draws on her background as a prosecutor and in-house compliance counsel to conduct risk assessments through the skilled eyes of an attorney, without the steep law firm fees. "I keep current on state and federal enforcement trends. My assessments prioritize a company's vulnerabilities and recommend actions so clients get the most legal risk mitigation for their dollar."
Amy's clients range from federal contractors to global corporations including in the nascent cannabis industry. They rely on her expertise in compliance, codes of ethics, staff training, corporate monitoring, auditing, and investigations."The savviest approach is to put your compliance program in place as a sword to prevent misconduct. If an incident occurs, your program then becomes your shield. Prompt reporting, a proactive response, and a solid plan to remediate future misconduct demonstrate a commitment to ethical practices and legal compliance."
A well-published thought leader, Amy is founding director and corporate secretary of the International Association of Independent Corporate Monitors. Through IAICM, she educates businesses and promotes service quality. Amy's place at the forefront of her profession reflects leadership ability honed by service as a U.S. Air Force officer. "The military taught me to translate strategic thinking into tactical action. “That's exactly what I bring to my clients," she concludes. "I translate compliance and ethics into a practical program so businesses can confidently move forward in a clear direction."
Bryna advises cannabis companies of all sizes, from startups to stars in the industry. Clients rely on her practical, real-world approach to navigating the industry’s complex and contradictory laws and regulations. Bryna’s clients range from growers, distributors, product manufacturers and ancillary businesses to traditional companies who work with and are impacted by cannabis laws. She advises on issues of regulatory compliance; risk avoidance; company formation; contracts and licensing; corporate transactions; advertising and product packaging; and brand strategy and intellectual property protection. She also performs legal due diligence for investors in the cannabis space and guides hemp, health and beauty brand clients in navigating CBD and FDA laws.
Bryna is also a skilled trial lawyer who has represented clients in an array of high-profile, “bet the company” cases in both trial and appellate court. Past representations include prominent food, pharmaceutical, entertainment, advertising, technology and consumer product companies. Bryna’s desire to play a small part in helping to correct the social injustices resulting from the war on drugs, combined with her significant branding, food and drug law experience, led her to form a legal practice catering to the cannabis industry in 2015. She serves as an adjunct professor at Chicago-Kent College of Law, where she taught Illinois’ first law course on cannabis law and policy, has lectured around the country on cannabis law, and serves as pro bono counsel to Chicago NORML. Bryna has been recognized by the National Law Journal as a “40 under 40” in Chicago and has been a “Super Lawyer” or “Rising Star” since 2010.
David N. Feldman concentrates his law practice on corporate and securities law and mergers and acquisitions, as well as general representation of public and private companies, entrepreneurs, investors, and private equity and venture capital firms. David has represented a wide range of clients in the legal cannabis and psychedelics industries since 2013. He provides guidance on private placements, public offerings, loan structuring and fund formation for cannabis companies, as well as corporate structuring advice and applications for grow, processing and dispensary licenses. He also advises on risk assessment issues for large, multinational businesses seeking to enter the cannabis industry. The global guide Chambers & Partners ranked Mr. Feldman as a leading US attorney in cannabis law and one of only seven US lawyers in “band 1” for corporate and transactional work in the industry. In addition, the National Law Journal named him a “Cannabis Law Trailblazer” and Business Insider named him as a top lawyer in the cannabis industry. He has also been listed several times in the Top 200 Cannabis Lawyers published by Cannabis Law Digest. David is the former team lead of an AmLaw 100 firm’s 60-attorney Cannabis Industry Group. He frequently speaks at industry conferences and is quoted by numerous publications about legal developments and business and finance news in this rapidly expanding market. In addition to serving as Managing Partner of Feldman Legal Advisors PLLC, he is co-founder and CEO of Skip Intro Advisors, LLC, a cannabis and psychedelics-focused business consutling firm focused on strategic guidance, finance and M&A and regulatory advice. In a recent win, last year he served as M&A advisor and also counsel to Keystone Canna Remedies, a three-dispensary group in Pennsylvania, in their sale to TerrAscend at a $70 million enterprise value.
David also advises emerging growth companies in a range of industries with regard to alternatives to traditional financing through initial public offerings, and is considered an authority on public offerings through SEC Regulation A+. He published a book on that subject, called Regulation A+ and Other Alternatives to a Traditional IPO (John Wiley & Sons), in 2018. David has also published The Entrepreneur’s Growth Startup Handbook: 7 Secrets to Venture Funding and Growth Success (2013) and the award-winning Reverse Mergers and Other Alternatives to a Traditional IPO (First Edition 2006, Second Edition 2009). A Wharton School and University of Pennsylvania Law School graduate and former Chair of Wharton’s worldwide alumni, David is not just a lawyer – he’s a community builder. He’s run, built, bought, invested in, and sold businesses. He feels his clients’ pain but provides the objective outsider’s point of view that founders need.
Jessica currently serves as a Cannabis and Intellectual Property attorney at Bressler Amery & Ross, a multidisciplinary law firm with over 175 attorneys and offices in New Jersey, New York, Florida, Alabama and Washington, DC. Jessica also services as outside General Counsel for the national organization Minorities for Medical Marijuana and sits on the Policy Committee for the Minority Cannabis Business Association. Jessica also sits on the board of advisors for QA Canna, a quality assurance company based in NJ. Prior to joining Bressler, Jessica was the co-founding partner at MGA Law PC, a boutique business law firm with a special focus oncannabis.
As a cannabis attorney, Jessica Gonzalez assists cannabis clients navigate the legal cannabis and hemp industry in the tristate area. She has counseled start up and medium sized cannabis/CBD companies on various matters, including corporate entity set-up, state and local compliance, private offering documents and applications for state cannabis licenses. Jessica also counsels corporate and individual clients on intellectual property procurement, prosecution, protection and enforcement for domestic and international trademarks. As cannabis advocate, Jessica has presented on both the municipal and state level on topics such as social justice/social equity, IP protection, cannabis legislation, state and federal banking and state cannabis licensing. Most recently, Jessica was selected as a 2020 fellow for the New Jersey New Leaders Council, a national organization that selects civically engaged leaders in their respective industry.
Please wait ...